Privacy Policy

This Privacy Policy (“Privacy Policy”) governs the processing and transfer of personal data collected or processed by Neurolief Ltd. (collectively with its subsidiaries and affiliated companies, including Neurolief, Inc., “Company”, “we”, “us” or “our”) when we provide our relevant “services”: through the purchase of our migraine treatment medical device (“Relivion®”), specifically the Relivion® transcutaneous electrical nerve stimulator is indicated for the acute treatment of migraine with or without aura in patients 18 years of age or older. It is a prescription device to be self-used at home. Or our depression treatment medical device (“Proliv™Rx external Combined Occipital and Trigeminal Afferent Stimulation (eCOT-AS) (“Proliv™Rx System”), specifically the Proliv™Rx System provides focal external Combined Occipital and Trigeminal Afferent Stimulation (eCOT-AS) treatment. It is intended as an adjunctive treatment for Major Depressive Disorder (MDD) in adults who failed to achieve satisfactory improvement from at least one previous antidepressant medication, for use at home or in clinic. It is a prescription-only device.(the “product/s”); using any of the products accompanying mobile applications (each an “App”); our cloud-based platform and data management tools made available for healthcare professionals in connection with the products (“Platform”); or accessing or using any of our related websites, web interfaces, dashboards, and landing pages (each a “website”). This Privacy Policy is an integral part of any other agreement between us (“Terms”). Any capitalized terms not defined herein shall have the meanings ascribed to them in the Terms, or under the applicable privacy laws.